Lupus Research Alliance Funds Study to Understand Connection between the Common Epstein-Barr Virus and Lupus
A study funded partly by the Lupus Research Alliance reveals insights into how a common viral infection may cause lupus...
Dr. Daniel Wallace Appointed to Lupus Therapeutics Board
Dr. Daniel Wallace Appointed to Lupus Therapeutics Board
New York, NY, July 18, 2019 — Renowned Dr. Daniel Wallace joined the Lupus Research Alliance (LRA) affiliate Lupus Therapeutics Board of Directors. This governing body, which includes lupus patients, family members and scientists, provides strategic insight and financial oversight to help Lupus Therapeutics achieve its mission –accelerate new ways to diagnose and treat lupus.
The full press release is available on the Lupus Therapeutics website.
